Invitation to Submit Proposals
DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for those affected by Epidermolysis bullosa (EB), today launches a call for Basic Science and Research Grants. This funding opportunity supports high-quality, original research projects focused on inherited forms of EB. DEBRA Research invites applications from researchers committed to driving meaningful scientific and clinical progress that can improve the quality of life for those living with this devastating genetic condition.
What We Are Looking For:
Projects that aim to:
- Advance scientific understanding of EB at the molecular and systemic levels
- Develop disease-modifying or curative therapies
- Prevent or treat severe consequences of EB
- Improve clinical care and symptom relief
- Overcome infrastructure, data, and technological barriers to enable therapy access
Eligible Applicants:
Academic researchers, non-profit organizations, hospitals, and mixed international consortia are welcome to apply. We strongly encourage collaborative, interdisciplinary proposals that bring novel tools, technologies, and approaches to the field – including but not limited to cell/gene therapies, small molecules, biologics, medical devices, and data-driven (in silico) approaches.
Application Process:
Our process follows a two-stage application model:
1. Expression of Interest (EOI)
As a first step, submit a concise outline using the EOI template (see website). EOIs will be assessed for their scientific, clinical, and commercial potential
2. Full Proposal (by invitation only)
In the second step, the shortlisted applicants will be invited to submit a full proposal via our grant management system (Grant Tracker). This stage includes peer review, a rebuttal opportunity, and a pitch presentation.
Key Dates – At a Glance:
|
Application Step |
Date |
|
EOI Deadline |
August 17, 2025 |
|
Full Proposal Deadline (by invitation) |
November 17, 2025 |
|
Funding Decision |
End of March 2026 |
|
Expected Project Start |
July 2026 |
For templates, further eligibility details, and guidance, visit www.debra-research.org or contact grants@debra-research.org.
About DEBRA Research
DEBRA Research is a non-profit organization dedicated to advancing treatments and cures for EB, a rare and life-limiting genetic condition. As the research arm of DEBRA Austria - a patient organization established in 1995 to support individuals living with EB – DEBRA Research collaborates globally with academia, biotech, pharma, patient organizations, and regulatory bodies to drive innovation. DEBRA Research focuses on translational research and clinical development to address the unmet needs of people living with EB. Its goal is to accelerate the discovery and development of treatments improving quality of life, while striving for a future where EB is curable – a “world without EB.”
For more information, please visit www.debra-research.org and follow us on LinkedIn.
Contacts
DEBRA Research GmbH
Email: grants@debra-research.org